Ontology type: schema:ScholarlyArticle
2022-05-13
AUTHORSDan Zhang, Jian Du, Min Yu, Linna Suo
ABSTRACTCritical roles of stem cell-extracellular vesicles (EVs) in the management of osteoporosis have been documented. Here, this study was designed to enlarge the research of the specific effects and underlying mechanism of urine-derived stem cells-EVs (USCs-EVs) on osteoporosis in diabetes rats. Firstly, miR-26a-5p and histone deacetylase 4 (HDAC4) expression in USCs of rats after diabetic osteoporosis (DOP) modeling induced by streptozotocin injection was determined, followed by study of their interaction. Then, USCs-EVs were co-cultured with osteogenic precursor cells, the effects of miRNA-26a-5p (miR-26a-5p) on osteoblasts, osteoclasts, bone mineralization deposition rate were evaluated. Meanwhile, the effect of USCs-EVs carrying miR-26a-5p on DOP rats was assessed. Elevated miR-26a-5p was seen in USCs-EVs which limited HDAC4 expression. Moreover, USCs-EVs delivered miR-26a-5p to osteogenic precursor cells, thereby promoting their differentiation, enhancing the activity of osteoblasts, and inhibiting the activity of osteoclasts, thereby preventing DOP through the activation of hypoxia inducible factor 1 subunit alpha (HIF-1α)/vascular endothelial growth factor A (VEGFA) pathway by repressing HDAC4. In a word, USCs-EVs-miR-26a-5p is a promising therapy for DOP by activating HIF-1α/VEGFA pathway through HDAC4 inhibition.Graphical abstract 1. USCs-EVs-miR-26a-5p targeted HDAC4 and limited HDAC4 expression. 2. miR-26a-5p was delivered by USCs-EVs into osteoblast precursor cells. 3. USCs-EVs-miR-26a-5p promoted the differentiation of osteoblast precursor cells into osteoblasts. 4. miR-26a-5p delivered by USCs-EVs could inhibit HDAC4. 5. USCs-EVs-miR-26a-5p could prevent the pathogenesis of DOP via HIF-1α/VEGFA aix. More... »
PAGES1-15
http://scigraph.springernature.com/pub.10.1007/s10565-022-09713-5
DOIhttp://dx.doi.org/10.1007/s10565-022-09713-5
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1147859301
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/35554780
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/06",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Biological Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0601",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Biochemistry and Cell Biology",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Department of Endocrinology, The Fourth Affiliated Hospital of China Medical University, 110032, Shenyang, People\u2019s Republic of China",
"id": "http://www.grid.ac/institutes/grid.412644.1",
"name": [
"Department of Endocrinology, The Fourth Affiliated Hospital of China Medical University, 110032, Shenyang, People\u2019s Republic of China"
],
"type": "Organization"
},
"familyName": "Zhang",
"givenName": "Dan",
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Endocrinology, The Fourth Affiliated Hospital of China Medical University, 110032, Shenyang, People\u2019s Republic of China",
"id": "http://www.grid.ac/institutes/grid.412644.1",
"name": [
"Department of Endocrinology, The Fourth Affiliated Hospital of China Medical University, 110032, Shenyang, People\u2019s Republic of China"
],
"type": "Organization"
},
"familyName": "Du",
"givenName": "Jian",
"id": "sg:person.015666321535.70",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015666321535.70"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Cell Biology, Key Laboratory of Cell Biology, Ministry of Public Health, and Key Laboratory of Medical Cell Biology, Ministry of Education, China Medical University, 110122, Shenyang, China",
"id": "http://www.grid.ac/institutes/grid.412449.e",
"name": [
"Department of Cell Biology, Key Laboratory of Cell Biology, Ministry of Public Health, and Key Laboratory of Medical Cell Biology, Ministry of Education, China Medical University, 110122, Shenyang, China"
],
"type": "Organization"
},
"familyName": "Yu",
"givenName": "Min",
"id": "sg:person.01354223110.58",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01354223110.58"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Endocrinology, The Fourth Affiliated Hospital of China Medical University, 110032, Shenyang, People\u2019s Republic of China",
"id": "http://www.grid.ac/institutes/grid.412644.1",
"name": [
"Department of Endocrinology, The Fourth Affiliated Hospital of China Medical University, 110032, Shenyang, People\u2019s Republic of China"
],
"type": "Organization"
},
"familyName": "Suo",
"givenName": "Linna",
"id": "sg:person.01062261032.33",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01062261032.33"
],
"type": "Person"
}
],
"citation": [
{
"id": "sg:pub.10.1186/1471-2164-14-111",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1040112254",
"https://doi.org/10.1186/1471-2164-14-111"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/s41413-019-0056-9",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1117497273",
"https://doi.org/10.1038/s41413-019-0056-9"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/onc.2017.51",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1084129939",
"https://doi.org/10.1038/onc.2017.51"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/s12276-020-0475-0",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1130014501",
"https://doi.org/10.1038/s12276-020-0475-0"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1186/s13287-021-02636-8",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1142565021",
"https://doi.org/10.1186/s13287-021-02636-8"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s40618-018-0828-x",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1100551601",
"https://doi.org/10.1007/s40618-018-0828-x"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/s41419-019-2159-z",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1123118884",
"https://doi.org/10.1038/s41419-019-2159-z"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/978-981-13-3681-2_16",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1112861124",
"https://doi.org/10.1007/978-981-13-3681-2_16"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1186/1472-6823-14-33",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1049986759",
"https://doi.org/10.1186/1472-6823-14-33"
],
"type": "CreativeWork"
}
],
"datePublished": "2022-05-13",
"datePublishedReg": "2022-05-13",
"description": "Critical roles of stem cell-extracellular vesicles (EVs) in the management of osteoporosis have been documented. Here, this study was designed to enlarge the research of the specific effects and underlying mechanism of urine-derived stem cells-EVs (USCs-EVs) on osteoporosis in diabetes rats. Firstly, miR-26a-5p and histone deacetylase 4 (HDAC4) expression in USCs of rats after diabetic osteoporosis (DOP) modeling induced by streptozotocin injection was determined, followed by study of their interaction. Then, USCs-EVs were co-cultured with osteogenic precursor cells, the effects of miRNA-26a-5p (miR-26a-5p) on osteoblasts, osteoclasts, bone mineralization deposition rate were evaluated. Meanwhile, the effect of USCs-EVs carrying miR-26a-5p on DOP rats was assessed. Elevated miR-26a-5p was seen in USCs-EVs which limited HDAC4 expression. Moreover, USCs-EVs delivered miR-26a-5p to osteogenic precursor cells, thereby promoting their differentiation, enhancing the activity of osteoblasts, and inhibiting the activity of osteoclasts, thereby preventing DOP through the activation of hypoxia inducible factor 1 subunit alpha (HIF-1\u03b1)/vascular endothelial growth factor A (VEGFA) pathway by repressing HDAC4. In a word, USCs-EVs-miR-26a-5p is a promising therapy for DOP by activating HIF-1\u03b1/VEGFA pathway through HDAC4 inhibition.Graphical abstract\n1. USCs-EVs-miR-26a-5p targeted HDAC4 and limited HDAC4 expression. 2. miR-26a-5p was delivered by USCs-EVs into osteoblast precursor cells. 3. USCs-EVs-miR-26a-5p promoted the differentiation of osteoblast precursor cells into osteoblasts. 4. miR-26a-5p delivered by USCs-EVs could inhibit HDAC4. 5. USCs-EVs-miR-26a-5p could prevent the pathogenesis of DOP via HIF-1\u03b1/VEGFA aix.",
"genre": "article",
"id": "sg:pub.10.1007/s10565-022-09713-5",
"inLanguage": "en",
"isAccessibleForFree": false,
"isPartOf": [
{
"id": "sg:journal.1095523",
"issn": [
"0742-2091",
"1573-6822"
],
"name": "Cell Biology and Toxicology",
"publisher": "Springer Nature",
"type": "Periodical"
}
],
"keywords": [
"precursor cells",
"HDAC4 expression",
"management of osteoporosis",
"miR-26a-5p",
"activity of osteoclasts",
"hypoxia inducible factor 1 subunit alpha",
"endothelial growth factor",
"stem cell extracellular vesicles",
"DOP rats",
"streptozotocin injection",
"diabetic osteoporosis",
"diabetes rats",
"histone deacetylase 4 (HDAC4) expression",
"activity of osteoblasts",
"cell extracellular vesicles",
"promising therapy",
"osteoblast precursor cells",
"HIF-1\u03b1/VEGFA",
"VEGFA pathway",
"osteoporosis",
"HDAC4 inhibition",
"growth factor",
"osteogenic precursor cells",
"rats",
"osteoclasts",
"HDAC4",
"specific effects",
"subunit alpha",
"cells",
"osteoblasts",
"critical role",
"expression",
"pathogenesis",
"therapy",
"pathway",
"VEGFA",
"differentiation",
"injection",
"activity",
"inhibition",
"effect",
"alpha",
"study",
"activation",
"AIx",
"management",
"factors",
"role",
"rate",
"vesicles",
"mechanism",
"USC",
"USCS",
"stem",
"DOP",
"research",
"interaction",
"words",
"modeling",
"deposition rate"
],
"name": "Urine-derived stem cells-extracellular vesicles ameliorate diabetic osteoporosis through HDAC4/HIF-1\u03b1/VEGFA axis by delivering microRNA-26a-5p",
"pagination": "1-15",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1147859301"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1007/s10565-022-09713-5"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"35554780"
]
}
],
"sameAs": [
"https://doi.org/10.1007/s10565-022-09713-5",
"https://app.dimensions.ai/details/publication/pub.1147859301"
],
"sdDataset": "articles",
"sdDatePublished": "2022-06-01T22:24",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220601/entities/gbq_results/article/article_932.jsonl",
"type": "ScholarlyArticle",
"url": "https://doi.org/10.1007/s10565-022-09713-5"
}
]
Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10565-022-09713-5'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10565-022-09713-5'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10565-022-09713-5'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10565-022-09713-5'
This table displays all metadata directly associated to this object as RDF triples.
175 TRIPLES
22 PREDICATES
93 URIs
76 LITERALS
5 BLANK NODES
Subject | Predicate | Object | |
---|---|---|---|
1 | sg:pub.10.1007/s10565-022-09713-5 | schema:about | anzsrc-for:06 |
2 | ″ | ″ | anzsrc-for:0601 |
3 | ″ | schema:author | Neabba5d3128041f59788a128efb2817a |
4 | ″ | schema:citation | sg:pub.10.1007/978-981-13-3681-2_16 |
5 | ″ | ″ | sg:pub.10.1007/s40618-018-0828-x |
6 | ″ | ″ | sg:pub.10.1038/onc.2017.51 |
7 | ″ | ″ | sg:pub.10.1038/s12276-020-0475-0 |
8 | ″ | ″ | sg:pub.10.1038/s41413-019-0056-9 |
9 | ″ | ″ | sg:pub.10.1038/s41419-019-2159-z |
10 | ″ | ″ | sg:pub.10.1186/1471-2164-14-111 |
11 | ″ | ″ | sg:pub.10.1186/1472-6823-14-33 |
12 | ″ | ″ | sg:pub.10.1186/s13287-021-02636-8 |
13 | ″ | schema:datePublished | 2022-05-13 |
14 | ″ | schema:datePublishedReg | 2022-05-13 |
15 | ″ | schema:description | Critical roles of stem cell-extracellular vesicles (EVs) in the management of osteoporosis have been documented. Here, this study was designed to enlarge the research of the specific effects and underlying mechanism of urine-derived stem cells-EVs (USCs-EVs) on osteoporosis in diabetes rats. Firstly, miR-26a-5p and histone deacetylase 4 (HDAC4) expression in USCs of rats after diabetic osteoporosis (DOP) modeling induced by streptozotocin injection was determined, followed by study of their interaction. Then, USCs-EVs were co-cultured with osteogenic precursor cells, the effects of miRNA-26a-5p (miR-26a-5p) on osteoblasts, osteoclasts, bone mineralization deposition rate were evaluated. Meanwhile, the effect of USCs-EVs carrying miR-26a-5p on DOP rats was assessed. Elevated miR-26a-5p was seen in USCs-EVs which limited HDAC4 expression. Moreover, USCs-EVs delivered miR-26a-5p to osteogenic precursor cells, thereby promoting their differentiation, enhancing the activity of osteoblasts, and inhibiting the activity of osteoclasts, thereby preventing DOP through the activation of hypoxia inducible factor 1 subunit alpha (HIF-1α)/vascular endothelial growth factor A (VEGFA) pathway by repressing HDAC4. In a word, USCs-EVs-miR-26a-5p is a promising therapy for DOP by activating HIF-1α/VEGFA pathway through HDAC4 inhibition.Graphical abstract 1. USCs-EVs-miR-26a-5p targeted HDAC4 and limited HDAC4 expression. 2. miR-26a-5p was delivered by USCs-EVs into osteoblast precursor cells. 3. USCs-EVs-miR-26a-5p promoted the differentiation of osteoblast precursor cells into osteoblasts. 4. miR-26a-5p delivered by USCs-EVs could inhibit HDAC4. 5. USCs-EVs-miR-26a-5p could prevent the pathogenesis of DOP via HIF-1α/VEGFA aix. |
16 | ″ | schema:genre | article |
17 | ″ | schema:inLanguage | en |
18 | ″ | schema:isAccessibleForFree | false |
19 | ″ | schema:isPartOf | sg:journal.1095523 |
20 | ″ | schema:keywords | AIx |
21 | ″ | ″ | DOP |
22 | ″ | ″ | DOP rats |
23 | ″ | ″ | HDAC4 |
24 | ″ | ″ | HDAC4 expression |
25 | ″ | ″ | HDAC4 inhibition |
26 | ″ | ″ | HIF-1α/VEGFA |
27 | ″ | ″ | USC |
28 | ″ | ″ | USCS |
29 | ″ | ″ | VEGFA |
30 | ″ | ″ | VEGFA pathway |
31 | ″ | ″ | activation |
32 | ″ | ″ | activity |
33 | ″ | ″ | activity of osteoblasts |
34 | ″ | ″ | activity of osteoclasts |
35 | ″ | ″ | alpha |
36 | ″ | ″ | cell extracellular vesicles |
37 | ″ | ″ | cells |
38 | ″ | ″ | critical role |
39 | ″ | ″ | deposition rate |
40 | ″ | ″ | diabetes rats |
41 | ″ | ″ | diabetic osteoporosis |
42 | ″ | ″ | differentiation |
43 | ″ | ″ | effect |
44 | ″ | ″ | endothelial growth factor |
45 | ″ | ″ | expression |
46 | ″ | ″ | factors |
47 | ″ | ″ | growth factor |
48 | ″ | ″ | histone deacetylase 4 (HDAC4) expression |
49 | ″ | ″ | hypoxia inducible factor 1 subunit alpha |
50 | ″ | ″ | inhibition |
51 | ″ | ″ | injection |
52 | ″ | ″ | interaction |
53 | ″ | ″ | management |
54 | ″ | ″ | management of osteoporosis |
55 | ″ | ″ | mechanism |
56 | ″ | ″ | miR-26a-5p |
57 | ″ | ″ | modeling |
58 | ″ | ″ | osteoblast precursor cells |
59 | ″ | ″ | osteoblasts |
60 | ″ | ″ | osteoclasts |
61 | ″ | ″ | osteogenic precursor cells |
62 | ″ | ″ | osteoporosis |
63 | ″ | ″ | pathogenesis |
64 | ″ | ″ | pathway |
65 | ″ | ″ | precursor cells |
66 | ″ | ″ | promising therapy |
67 | ″ | ″ | rate |
68 | ″ | ″ | rats |
69 | ″ | ″ | research |
70 | ″ | ″ | role |
71 | ″ | ″ | specific effects |
72 | ″ | ″ | stem |
73 | ″ | ″ | stem cell extracellular vesicles |
74 | ″ | ″ | streptozotocin injection |
75 | ″ | ″ | study |
76 | ″ | ″ | subunit alpha |
77 | ″ | ″ | therapy |
78 | ″ | ″ | vesicles |
79 | ″ | ″ | words |
80 | ″ | schema:name | Urine-derived stem cells-extracellular vesicles ameliorate diabetic osteoporosis through HDAC4/HIF-1α/VEGFA axis by delivering microRNA-26a-5p |
81 | ″ | schema:pagination | 1-15 |
82 | ″ | schema:productId | N01da698273344710b7632b242b8e7c3a |
83 | ″ | ″ | N8ff4ec8c898b4b99a2875332ad65c49a |
84 | ″ | ″ | N95fcd179bb0549df89c01c80635ceb8d |
85 | ″ | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1147859301 |
86 | ″ | ″ | https://doi.org/10.1007/s10565-022-09713-5 |
87 | ″ | schema:sdDatePublished | 2022-06-01T22:24 |
88 | ″ | schema:sdLicense | https://scigraph.springernature.com/explorer/license/ |
89 | ″ | schema:sdPublisher | Ne824b56fc24a44099644aae5c7284f3f |
90 | ″ | schema:url | https://doi.org/10.1007/s10565-022-09713-5 |
91 | ″ | sgo:license | sg:explorer/license/ |
92 | ″ | sgo:sdDataset | articles |
93 | ″ | rdf:type | schema:ScholarlyArticle |
94 | N01da698273344710b7632b242b8e7c3a | schema:name | pubmed_id |
95 | ″ | schema:value | 35554780 |
96 | ″ | rdf:type | schema:PropertyValue |
97 | N8ff4ec8c898b4b99a2875332ad65c49a | schema:name | doi |
98 | ″ | schema:value | 10.1007/s10565-022-09713-5 |
99 | ″ | rdf:type | schema:PropertyValue |
100 | N95fcd179bb0549df89c01c80635ceb8d | schema:name | dimensions_id |
101 | ″ | schema:value | pub.1147859301 |
102 | ″ | rdf:type | schema:PropertyValue |
103 | Nc407a35011b3499a98c563931cc055d9 | rdf:first | sg:person.015666321535.70 |
104 | ″ | rdf:rest | Nf94e65cba4cf4201a5149f06fd65d050 |
105 | Ne65e97ad2199452c93fb0c8aed0b0035 | schema:affiliation | grid-institutes:grid.412644.1 |
106 | ″ | schema:familyName | Zhang |
107 | ″ | schema:givenName | Dan |
108 | ″ | rdf:type | schema:Person |
109 | Ne824b56fc24a44099644aae5c7284f3f | schema:name | Springer Nature - SN SciGraph project |
110 | ″ | rdf:type | schema:Organization |
111 | Neabba5d3128041f59788a128efb2817a | rdf:first | Ne65e97ad2199452c93fb0c8aed0b0035 |
112 | ″ | rdf:rest | Nc407a35011b3499a98c563931cc055d9 |
113 | Nf011d54a07be4fcca1e662a6685be5d9 | rdf:first | sg:person.01062261032.33 |
114 | ″ | rdf:rest | rdf:nil |
115 | Nf94e65cba4cf4201a5149f06fd65d050 | rdf:first | sg:person.01354223110.58 |
116 | ″ | rdf:rest | Nf011d54a07be4fcca1e662a6685be5d9 |
117 | anzsrc-for:06 | schema:inDefinedTermSet | anzsrc-for: |
118 | ″ | schema:name | Biological Sciences |
119 | ″ | rdf:type | schema:DefinedTerm |
120 | anzsrc-for:0601 | schema:inDefinedTermSet | anzsrc-for: |
121 | ″ | schema:name | Biochemistry and Cell Biology |
122 | ″ | rdf:type | schema:DefinedTerm |
123 | sg:journal.1095523 | schema:issn | 0742-2091 |
124 | ″ | ″ | 1573-6822 |
125 | ″ | schema:name | Cell Biology and Toxicology |
126 | ″ | schema:publisher | Springer Nature |
127 | ″ | rdf:type | schema:Periodical |
128 | sg:person.01062261032.33 | schema:affiliation | grid-institutes:grid.412644.1 |
129 | ″ | schema:familyName | Suo |
130 | ″ | schema:givenName | Linna |
131 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01062261032.33 |
132 | ″ | rdf:type | schema:Person |
133 | sg:person.01354223110.58 | schema:affiliation | grid-institutes:grid.412449.e |
134 | ″ | schema:familyName | Yu |
135 | ″ | schema:givenName | Min |
136 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01354223110.58 |
137 | ″ | rdf:type | schema:Person |
138 | sg:person.015666321535.70 | schema:affiliation | grid-institutes:grid.412644.1 |
139 | ″ | schema:familyName | Du |
140 | ″ | schema:givenName | Jian |
141 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015666321535.70 |
142 | ″ | rdf:type | schema:Person |
143 | sg:pub.10.1007/978-981-13-3681-2_16 | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1112861124 |
144 | ″ | ″ | https://doi.org/10.1007/978-981-13-3681-2_16 |
145 | ″ | rdf:type | schema:CreativeWork |
146 | sg:pub.10.1007/s40618-018-0828-x | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1100551601 |
147 | ″ | ″ | https://doi.org/10.1007/s40618-018-0828-x |
148 | ″ | rdf:type | schema:CreativeWork |
149 | sg:pub.10.1038/onc.2017.51 | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1084129939 |
150 | ″ | ″ | https://doi.org/10.1038/onc.2017.51 |
151 | ″ | rdf:type | schema:CreativeWork |
152 | sg:pub.10.1038/s12276-020-0475-0 | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1130014501 |
153 | ″ | ″ | https://doi.org/10.1038/s12276-020-0475-0 |
154 | ″ | rdf:type | schema:CreativeWork |
155 | sg:pub.10.1038/s41413-019-0056-9 | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1117497273 |
156 | ″ | ″ | https://doi.org/10.1038/s41413-019-0056-9 |
157 | ″ | rdf:type | schema:CreativeWork |
158 | sg:pub.10.1038/s41419-019-2159-z | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1123118884 |
159 | ″ | ″ | https://doi.org/10.1038/s41419-019-2159-z |
160 | ″ | rdf:type | schema:CreativeWork |
161 | sg:pub.10.1186/1471-2164-14-111 | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1040112254 |
162 | ″ | ″ | https://doi.org/10.1186/1471-2164-14-111 |
163 | ″ | rdf:type | schema:CreativeWork |
164 | sg:pub.10.1186/1472-6823-14-33 | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1049986759 |
165 | ″ | ″ | https://doi.org/10.1186/1472-6823-14-33 |
166 | ″ | rdf:type | schema:CreativeWork |
167 | sg:pub.10.1186/s13287-021-02636-8 | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1142565021 |
168 | ″ | ″ | https://doi.org/10.1186/s13287-021-02636-8 |
169 | ″ | rdf:type | schema:CreativeWork |
170 | grid-institutes:grid.412449.e | schema:alternateName | Department of Cell Biology, Key Laboratory of Cell Biology, Ministry of Public Health, and Key Laboratory of Medical Cell Biology, Ministry of Education, China Medical University, 110122, Shenyang, China |
171 | ″ | schema:name | Department of Cell Biology, Key Laboratory of Cell Biology, Ministry of Public Health, and Key Laboratory of Medical Cell Biology, Ministry of Education, China Medical University, 110122, Shenyang, China |
172 | ″ | rdf:type | schema:Organization |
173 | grid-institutes:grid.412644.1 | schema:alternateName | Department of Endocrinology, The Fourth Affiliated Hospital of China Medical University, 110032, Shenyang, People’s Republic of China |
174 | ″ | schema:name | Department of Endocrinology, The Fourth Affiliated Hospital of China Medical University, 110032, Shenyang, People’s Republic of China |
175 | ″ | rdf:type | schema:Organization |